Hangzhou & Shaoxing, China (March 19, 2018) – Ascletis, a China-based biotechnology company focused on innovative drug development, announced today that Dr. Vivian Chen, former VP of Eli Lilly China, joined Ascletis as Vice President of Corporate Affairs, Dr. Chen will be responsible for the corporate affairs and government relations.
“We are pleased to welcome Vivian to our senior leadership team,” said Jinzi J. Wu, PhD., Founder, Chief Executive Officer of Ascletis. “With her over 2 decades experience in public and private sector both in USA and China, we believe Vivian will bring us her expertise and extensive experience, she will contribute significantly to our corporate strategies and development plans.”
“I am very much encouraged about joining Ascletis at this exciting time, which represents the best time of China bio-tech industry development. I am holding full confidence about the future development of Ascletis, and will work with my colleagues closely to bring the best treatment to fill unmet needs of Chinese liver disease patients.” Dr. Vivian Chen commented.
Vivian Chen has more than 20 years of public and private sector experience in USA and China. In China, Vivian has held several senior management positions in health-care sector in the areas of government relations, corporate affairs and market access. Her previous employers include RDPAC, Becton Dickinson, Eli Lilly and Abbott, she functioned as Vice President of Government Relations and Corporate Affairs at Eli Lilly China. In USA, her professional experiences include an economist for the World Bank, US Department of Labor in Washington, the consultant in the Asian Development Bank and United Nations Headquarter. Vivian has written actively on China healthcare and pharmaceutical issues on major industry news reports and served as senior persons at several HC-based local organizations during her RDPAC period. Currently, she is the council member of China Health Economic Association and China Medical Insurance association. Vivian earns PhD in economics at the University of Utah, and served as a Research Fellow at the University of Pennsylvania and adjunct teacher at George Washington University. She has a BA in international economics from Fudan University in Shanghai.